𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Antibody-Induced Failure of Botulinum Toxin A Therapy in Cosmetic Indications

✍ Scribed by DIRK DRESSLER; KAI WOHLFAHRT; ELLEN MEYER-ROGGE; LUITGARD WIEST; HANS BIGALKE

Book ID
109077086
Publisher
John Wiley and Sons
Year
2010
Tongue
English
Weight
792 KB
Volume
36
Category
Article
ISSN
1076-0512

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

Clinical presentation and management of
Clinical presentation and management of antibody-induced failure of botulinum toxin therapy
✍ Dirk Dressler πŸ“‚ Article πŸ“… 2004 πŸ› John Wiley and Sons 🌐 English βš– 150 KB

Therapy with botulinum toxin (BT) can fail due to numerous reasons, including failure due to formation of antibodies against BT (BT-AB, AB-TF). AB-TF is a secondary therapy failure, i.e. it occurs during the course of an ongoing BT therapy. It can be subjective or objective, temporary or permanent,

Botulinum toxin antibody type A titres a
Botulinum toxin antibody type A titres after cessation of botulinum toxin therapy
✍ Dirk Dressler; Hans Bigalke πŸ“‚ Article πŸ“… 2001 πŸ› John Wiley and Sons 🌐 English βš– 145 KB

## Abstract In some patients, therapy with botulinum toxin type A (BT‐A) becomes ineffective due to formation of antibodies (BT‐A‐AB). The time course of BT‐A‐AB titres after cessation of BT‐A therapy was quantitatively studied to determine whether and when they might drop. Thirteen patients (eight